Finance

Lists
Why is ANNX down 2.60%?
Dive Deeper
ANNX:NASDAQ
Annexon Inc
$4.12
-2.60%
(-0.11) 1D
$4.12
0.00% (0.00)
After hours
Closed: Oct 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANNX...
Open
$4.18
High
$4.38
Low
$4.12
Mkt. cap
781.07M
Avg. vol.
3.02M
Volume
3.92M
52-wk high
$7.18
52-wk low
$2.54
EPS
-$1.15
Beta
1.21
Shares outstanding
189.58M
No. of employees
92
Open
$4.18
High
$4.38
Low
$4.12
Mkt. cap
781.07M
Avg. vol.
3.02M
Volume
3.92M
52-wk high
$7.18
52-wk low
$2.54
EPS
-$1.15
Beta
1.21
Shares outstanding
189.58M
No. of employees
92
News stories
From web sources and news partners
About Annexon Inc
CEO-
Employees92
Founded2011
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websiteannexonbio.com
Analyst ratings
Based on 9 analysts giving stock ratings to ANNX in the past 3 months
Buy
Buy
6
Hold
2
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ANNX in the last 3 months.
Highest
Current $4.12
$27.00 (+555.34%)
Average
$13.36 (+224.27%)
Lowest
$3.00 (-27.18%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Reiterated
$15.00
+264.1%
09/30/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
$8.00
+94.2%
09/28/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/12/2026
Ananda Ghosh
H.C. Wainwright
Buy
Reiterated
$14.00
+239.8%
08/14/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$27.00
+555.3%
08/13/2026
Joseph Stringer
Needham
Buy
Maintained
$25.00
+506.8%
08/12/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
$7.00
+69.9%
08/06/2026
Jonathan Wolleben
Citizens JMP
Sell
Initiated
$3.00
-27.2%
07/21/2026
Unknown Analyst
Raymond James
Hold
Initiated
$7.85
+90.5%
07/21/2026
William Maughan
Clear Street
Buy
Maintained
$17.00
+312.6%
03/30/2026
Last report
Aug 12, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.28 / -$0.24
-15.17%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
49.70M
42.66M
35.79M
46.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.32M
7.60M
10.27M
10.64M
Operating expense
57.02M
50.26M
46.05M
57.23M
Total operating expenses
57.02M
50.26M
46.05M
57.23M
Operating income
-57.02M
-50.26M
-46.05M
-57.23M
Other non operating income
-
-
-
-
EBT including unusual items
-54.92M
-48.26M
-44.14M
-55.35M
EBT excluding unusual items
-54.92M
-48.26M
-44.14M
-55.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-54.92M
-48.26M
-44.14M
-55.35M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.28
-0.23
-0.28
Interest and investment income
2.10M
2.00M
1.91M
1.88M
Interest expense
-
-
-
-
Net interest expenses
2.10M
2.00M
1.91M
1.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
-56.47M
-49.72M
-45.51M
-56.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps